Earnings summaries and quarterly performance for ALEXANDRIA REAL ESTATE EQUITIES.
Executive leadership at ALEXANDRIA REAL ESTATE EQUITIES.
Peter M. Moglia
Chief Executive Officer and Chief Investment Officer
Andres R. Gavinet
Chief Accounting Officer
Daniel J. Ryan
Co-President and Regional Market Director – San Diego
Gary D. Dean
Executive Vice President – Real Estate Legal Affairs
Hunter L. Kass
Co-President and Regional Market Director – Greater Boston
Jackie B. Clem
General Counsel and Secretary
Joel S. Marcus
Executive Chairman and Founder
John Hart Cole
Executive Vice President – Capital Markets/Strategic Operations and Co-Regional Market Director – Seattle
Joseph Hakman
Co-Chief Operating Officer and Chief Strategic Transactions Officer
Kristina A. Fukuzaki-Carlson
Executive Vice President – Business Operations
Lawrence J. Diamond
Co-Chief Operating Officer and Regional Market Director – Maryland
Madeleine T. Alsbrook
Executive Vice President – Talent Management
Marc E. Binda
Chief Financial Officer and Treasurer
Orraparn C. Lee
Executive Vice President – Accounting
Board of directors at ALEXANDRIA REAL ESTATE EQUITIES.
Research analysts who have asked questions during ALEXANDRIA REAL ESTATE EQUITIES earnings calls.
Dylan Burzinski
Green Street Advisors, LLC
6 questions for ARE
James Kammert
Evercore ISI
6 questions for ARE
Anthony Paolone
JPMorgan Chase & Co.
5 questions for ARE
Michael Carroll
RBC Capital Markets
5 questions for ARE
Richard Anderson
Wedbush Securities
5 questions for ARE
Vikram Malhotra
Mizuho Financial Group, Inc.
5 questions for ARE
Farrell Granath
Bank of America
4 questions for ARE
Omotayo Okusanya
Deutsche Bank AG
4 questions for ARE
Peter Abramowitz
Jefferies
3 questions for ARE
Wesley Golladay
Robert W. Baird & Co.
3 questions for ARE
Jamie Feldman
Wells Fargo & Company
2 questions for ARE
John Kim
BMO Capital Markets
2 questions for ARE
Nicholas Joseph
Citigroup
2 questions for ARE
Nick Joseph
Citigroup Inc.
2 questions for ARE
Georgi Dinkov
Mizuho
1 question for ARE
James Feldman
Wells Fargo
1 question for ARE
Joshua Dennerlein
BofA Securities
1 question for ARE
Michael Griffin
Citigroup Inc.
1 question for ARE
Nick
Virtue Capital
1 question for ARE
Thomas Catherwood
BTIG
1 question for ARE
William Catherwood
BTIG
1 question for ARE
Recent press releases and 8-K filings for ARE.
- On December 8, 2025, the Board authorized a new $500 million common stock repurchase program replacing the existing authorization expiring December 31, 2025.
- Under the current program, $258.2 million of shares were repurchased, primarily in January 2025.
- The new program permits purchases of up to $500 million of common stock through open-market, negotiated transactions, accelerated repurchases, derivatives, or other methods until December 31, 2026.
- Repurchase timing, price, and amount are at the Company’s discretion and are intended to be leverage-neutral, funded by net cash from operations after dividends and proceeds from dispositions and joint ventures.
- The Board authorized a new common stock repurchase program replacing the current authorization set to expire December 31, 2025; under the existing program, Alexandria repurchased $258.2 million of its shares, primarily in January 2025.
- The new program allows the repurchase of up to $500 million of common stock through December 31, 2026, in the open market or negotiated transactions (including accelerated share repurchases and derivatives).
- Repurchase timing, price, and amount will be determined at management’s discretion and may be suspended or discontinued; funding is expected to be on a leverage-neutral basis with net cash from operations after dividends and proceeds from real estate dispositions or joint ventures.
- 2025 guidance updated: Net loss per share of $(9.27) to $(7.89); FFO per share of $8.98 to $9.04 (midpoint $9.01).
- 2026 FFO per share guidance set at $6.25 to $6.55 (midpoint $6.40), a ~29% decline from 2025; Q4 2026 FFO per share expected at $1.40 to $1.60.
- Capex reduced to $1.7 billion annually for 2024–26 (-39% vs. 2021–23 average of $2.8 billion), funded by $2.9 billion of dispositions, $525 million net cash from operations after dividends, and $1.675 billion of debt paydown.
- Dividend cut: Q4 2025 dividend reduced by 45% to $0.72/share (from $1.32), conserving ~$410 million for 2026 capital needs.
- 2025 disposition program on track: $1.8 billion of completed or non-refundable deposits against a $1.5 billion target, split 58% stabilized, 21% land, 21% non-stabilized properties.
- Board declared a quarterly cash dividend of $0.72 per common share for 4Q25, payable January 15, 2026 to stockholders of record December 31, 2025.
- This represents a 45% decrease (down $0.60 per share) from the dividend declared for 3Q25.
- Reduction reflects a move to fortify the balance sheet and preserve approximately $410 million in annual liquidity.
- The dividend yields 5.4% based on Alexandria’s closing stock price on December 1, 2025.
- Introduced seven strategic levers to improve occupancy, reduce CapEx and G&A, focus on core mega campuses (2026 pipeline 86% leased), exit Montreal assets and maintain optional share buybacks.
- 2025 dispositions expected to reach up to $1.8 billion (closed $695 M, $840 M expected to close, $296 M under LOI) to bolster leverage and fund operations.
- 2026 FFO per share diluted as adjusted guidance set at $6.25–$6.55 (midpoint $6.40), reflecting an 8.5% same-property NOI decline and 88.5% year-end occupancy.
- Board approved a 45% dividend reduction to generate $410 million of additional capital, aligning dividend yield with S&P 500 REIT peers.
- The life-science real estate market faces an oversupply surge post-COVID and a 62% drop in demand since 2021, driving occupancy declines and slower lease-ups in key submarkets.
- For 2026, management outlined seven strategic levers: maintain a strong, flexible balance sheet; reduce capital spending; complete non-core dispositions; boost occupancy and NOI via mega campuses; optimize G&A; preserve growth optionality on mega campuses; and consider opportunistic share buybacks.
- Initial 2026 guidance projects FFO per share diluted as adjusted of $6.25–$6.55 (midpoint $6.40), with 75% of the year-over-year decline stemming from core operational pressures, lower capitalized interest, and non-core asset dispositions.
- Since 2021, >$7.5 billion of non-core assets have been recycled; the goal is to have 90–95% of annual rental revenue from mega campuses by end-2026 and reduce non-core assets to 5–10%, supported by a pipeline that is 86% leased.
- The balance sheet remains robust with ~$5 billion of liquidity, a weighted average debt maturity of 11.6 years, and a Q4 2026 leverage target of 5.6–6.2× net debt/EBITDA.
- Management identified seven strategic “levers” to drive growth, including improving occupancy and NOI, managing G&A, maintaining mega campus optionality, pausing low-conviction CapEx, and considering opportunistic share buybacks.
- The 2026 development pipeline is 86% leased, highlighted by the upcoming Bristol Myers Squibb delivery; key projects in Texas and Montreal have been paused or exited to redeploy capital to higher-conviction assets.
- A large-scale non-core disposition program targets $2.9 billion in 2026, aiming to reduce non-core rental revenue from ~20% today to 5–10%, with 90–95% of annual rental revenue from core mega campuses by year-end 2026.
- Alexandria’s mega campuses continue to outperform, achieving 110% of the next five largest life science owners’ Boston leasing volume and 150% in San Diego through its proprietary clustering model of space, place, and service.
- Initial 2026 guidance assumes up to 500 ksf of potential vacancy, year-end occupancy of 88.5%, net debt/EBITDA of 5.6–6.2×, and $60–90 million of realized venture gains, underpinned by a 45% dividend reduction to generate $410 million of additional capital.
- The Schall Law Firm is investigating Alexandria Real Estate Equities, Inc. (NYSE: ARE) for alleged securities law violations.
- The probe focuses on whether the company issued false or misleading statements or failed to disclose material information.
- Alexandria's Q3 2025 results (reported October 27, 2025) showed missed earnings, declining revenues, and a 7% decline in adjusted funds from operations, leading to a 19.2% share drop.
- Investors who suffered losses are urged to contact the Schall Law Firm to discuss potential claims free of charge.
- 2026 FFO per share (diluted, as adjusted) expected midpoint range of $6.25–$6.85 for the year ending December 31, 2026.
- Same property NOI fell 6.0% in 3Q25 vs. 3Q24, and operating occupancy declined to 90.6% as of September 30, 2025, marking four consecutive quarters of decreases.
- $4.2 billion of real estate basis capitalized in YTD 3Q25 for pipeline projects, with anticipated pre-construction milestones on April 14, 2026.
- $1.0 billion of pending dispositions (subject to LOIs and PSAs) expected to close in late 4Q25; G&A expenses are projected to be $49 million lower for 2025, with about half the savings continuing in 2026.
- Additional 2026 guidance will be introduced on December 3, 2025 at the company’s Investor Day.
- FFO per share diluted as adjusted of $2.22; operating occupancy of 90.6%, down 110 bps on an apples-to-apples basis in Q3 ’25
- Leasing volume of 1.2 million sq ft with rental rate growth of 15.2% (6.1% cash) on renewals and new leases
- 2025 guidance updated: FFO per share midpoint cut by $0.25 to $9.01, year-end occupancy target lowered to 90%–91.6%, and net debt to annualized adjusted EBITDA now guided to 5.5–6.0x
- Strong liquidity of $4.2 billion, 11.6-year weighted average debt maturity; non-core dispositions of $1.5 billion planned and $324 million of impairments recognized in Q3
Quarterly earnings call transcripts for ALEXANDRIA REAL ESTATE EQUITIES.
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more